Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Vancouver, WA
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Vancouver, WA
Click here to add this to my saved trials
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
La Crosse, WI
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
La Crosse, WI
Click here to add this to my saved trials
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Madison, WI
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Status: Enrolling
Updated:  1/23/2017
mi
from
Hato Rey,
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Status: Enrolling
Updated: 1/23/2017
mi
from
Hato Rey,
Click here to add this to my saved trials
Siemens 3-D C-Arm CT of the Heart Chambers
Three Dimensional C-Arm Computed Tomography of the Heart Chambers
Status: Enrolling
Updated:  1/31/2017
Cleveland Clinic
mi
from
Cleveland, OH
Siemens 3-D C-Arm CT of the Heart Chambers
Three Dimensional C-Arm Computed Tomography of the Heart Chambers
Status: Enrolling
Updated: 1/31/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety Monitoring of Patients Having Pulmonary Vein Ablation
Pulmonary Vein Ablation for Atrial Fibrillation: Safety Monitoring by Transesphoageal Echo, Intracardiac Echo and Computed Tomography and Assessment of Predictors of Recurrence and of Hypercoagulable State
Status: Enrolling
Updated:  2/2/2017
Cleveland Clinic
mi
from
Cleveland, OH
Safety Monitoring of Patients Having Pulmonary Vein Ablation
Pulmonary Vein Ablation for Atrial Fibrillation: Safety Monitoring by Transesphoageal Echo, Intracardiac Echo and Computed Tomography and Assessment of Predictors of Recurrence and of Hypercoagulable State
Status: Enrolling
Updated: 2/2/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Implantable Loop Recorders in Post-atrial Fibrillation (AF) Ablation: RPAF-A
Implantable Loop Recorders in Post-AF Ablation: RPAF-A
Status: Enrolling
Updated:  2/9/2017
Cleveland Clinic
mi
from
Cleveland, OH
Implantable Loop Recorders in Post-atrial Fibrillation (AF) Ablation: RPAF-A
Implantable Loop Recorders in Post-AF Ablation: RPAF-A
Status: Enrolling
Updated: 2/9/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Selective AV Nodal Vagal Stimulation For Reduction of the Ventricular Rate During Atrial Fibrillation
Selective AV Nodal Vagal Stimulation For Reduction of the Ventricular Rate During Atrial Fibrillation
Status: Enrolling
Updated:  2/9/2017
Cleveland Clinic
mi
from
Cleveland, OH
Selective AV Nodal Vagal Stimulation For Reduction of the Ventricular Rate During Atrial Fibrillation
Selective AV Nodal Vagal Stimulation For Reduction of the Ventricular Rate During Atrial Fibrillation
Status: Enrolling
Updated: 2/9/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Timing of Direct Current Cardioversion (DCC) in Patients Undergoing Ablation of Persistent/Permanent Atrial Fibrillation
Timing of DCC in Patients Undergoing Pulmonary Vein Isolation Ablation (PVI) of Persistent/Permanent Atrial Fibrillation
Status: Enrolling
Updated:  2/9/2017
Cleveland Clinic
mi
from
Cleveland, OH
Timing of Direct Current Cardioversion (DCC) in Patients Undergoing Ablation of Persistent/Permanent Atrial Fibrillation
Timing of DCC in Patients Undergoing Pulmonary Vein Isolation Ablation (PVI) of Persistent/Permanent Atrial Fibrillation
Status: Enrolling
Updated: 2/9/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
A Study of the Effects of BMS-919373 on Atrial Effective Refractory Period in Subjects With a Dual-Chamber Pacemaker
Status: Enrolling
Updated:  2/14/2017
Local Institution
mi
from
Austin, TX
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
A Study of the Effects of BMS-919373 on Atrial Effective Refractory Period in Subjects With a Dual-Chamber Pacemaker
Status: Enrolling
Updated: 2/14/2017
Local Institution
mi
from
Austin, TX
Click here to add this to my saved trials
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
A Study of the Effects of BMS-919373 on Atrial Effective Refractory Period in Subjects With a Dual-Chamber Pacemaker
Status: Enrolling
Updated:  2/14/2017
University of Calgary
mi
from
Calgary,
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
A Study of the Effects of BMS-919373 on Atrial Effective Refractory Period in Subjects With a Dual-Chamber Pacemaker
Status: Enrolling
Updated: 2/14/2017
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Improving Anticoagulation Control in VISN 1
Improving Anticoagulation Control in VISN 1
Status: Enrolling
Updated:  2/28/2017
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
mi
from
Bedford, MA
Improving Anticoagulation Control in VISN 1
Improving Anticoagulation Control in VISN 1
Status: Enrolling
Updated: 2/28/2017
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
mi
from
Bedford, MA
Click here to add this to my saved trials
One More Magnetic Resonance Imaging
One More Magnetic Resonance Imaging
Status: Enrolling
Updated:  2/28/2017
Saint Lukes Hospital
mi
from
Kansas City, MO
One More Magnetic Resonance Imaging
One More Magnetic Resonance Imaging
Status: Enrolling
Updated: 2/28/2017
Saint Lukes Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation
Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation (Vagus Nerve Study)
Status: Enrolling
Updated:  3/2/2017
Intermountain Medical Center
mi
from
Murray, UT
Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation
Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation (Vagus Nerve Study)
Status: Enrolling
Updated: 3/2/2017
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  3/8/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 3/8/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  3/8/2017
New York University School of Medicine
mi
from
NY, NY
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 3/8/2017
New York University School of Medicine
mi
from
NY, NY
Click here to add this to my saved trials
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  3/8/2017
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 3/8/2017
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Click here to add this to my saved trials
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation
Status: Enrolling
Updated:  3/8/2017
University Heart Center Hamburg
mi
from
Hamburg,
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation
Status: Enrolling
Updated: 3/8/2017
University Heart Center Hamburg
mi
from
Hamburg,
Click here to add this to my saved trials
Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation
Concomitant Renal Denervation Therapy in Hypertensive Patients Undergoing Atrial Fibrillation Ablation - A Feasibility Study
Status: Enrolling
Updated:  3/21/2017
The Mayo Clinic
mi
from
Rochester, MN
Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation
Concomitant Renal Denervation Therapy in Hypertensive Patients Undergoing Atrial Fibrillation Ablation - A Feasibility Study
Status: Enrolling
Updated: 3/21/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)
Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)
Status: Enrolling
Updated:  4/4/2017
Indiana University
mi
from
Indianapolis, IN
Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)
Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)
Status: Enrolling
Updated: 4/4/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist
Real-world Comparative Effectiveness of Apixaban Versus VKA
Status: Enrolling
Updated:  4/4/2017
Clinical Research Facility
mi
from
New York, NY
Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist
Real-world Comparative Effectiveness of Apixaban Versus VKA
Status: Enrolling
Updated: 4/4/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist
Real-world Comparative Effectiveness of Dabigatran Versus VKA
Status: Enrolling
Updated:  4/4/2017
Clinical Research Facility
mi
from
New York, NY
Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist
Real-world Comparative Effectiveness of Dabigatran Versus VKA
Status: Enrolling
Updated: 4/4/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Real-world Comparative Effectiveness of Rivaroxaban Versus VKA
Real-world Comparative Effectiveness of Rivaroxaban Versus VKA
Status: Enrolling
Updated:  4/4/2017
Clinical Research Facility
mi
from
New York, NY
Real-world Comparative Effectiveness of Rivaroxaban Versus VKA
Real-world Comparative Effectiveness of Rivaroxaban Versus VKA
Status: Enrolling
Updated: 4/4/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
Status: Enrolling
Updated:  4/4/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
Status: Enrolling
Updated: 4/4/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers
Comparison of the Effects of the Direct Thrombin Inhibitor, Pradaxa, to That of Warfarin on Bone Mass and Bone Turnover Markers
Status: Enrolling
Updated:  4/10/2017
University of Connecticut Health Center
mi
from
Farmington, CT
Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers
Comparison of the Effects of the Direct Thrombin Inhibitor, Pradaxa, to That of Warfarin on Bone Mass and Bone Turnover Markers
Status: Enrolling
Updated: 4/10/2017
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Status: Enrolling
Updated:  4/19/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Status: Enrolling
Updated: 4/19/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Status: Enrolling
Updated:  4/25/2017
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Status: Enrolling
Updated: 4/25/2017
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Click here to add this to my saved trials
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Status: Enrolling
Updated:  4/25/2017
St. David's Medical Center
mi
from
Austin, TX
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Status: Enrolling
Updated: 4/25/2017
St. David's Medical Center
mi
from
Austin, TX
Click here to add this to my saved trials
ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
Status: Enrolling
Updated:  5/3/2017
Duke University Health System
mi
from
Durham, NC
ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
Status: Enrolling
Updated: 5/3/2017
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Mission Viejo, CA
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Kansas City, MO
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Toledo, OH
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Huntsville, AL
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
New Haven, CT
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Trumbull, CT
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Trumbull, CT
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Pensacola, FL
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Pensacola, FL
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
West Des Moines, IA
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Bangor, ME
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Bangor, ME
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Scarborough, ME
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Boston, MA
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Burlington, MA
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Burlington, MA
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Charleston, SC
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Austin, TX
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Richmond, VA
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Omaha, NE
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
DECAAF: DE-MRI Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  6/1/2017
Florida Heart Rhythm Institute
mi
from
Tampa, FL
DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
DECAAF: DE-MRI Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 6/1/2017
Florida Heart Rhythm Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
DECAAF: DE-MRI Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
Status: Enrolling
Updated:  6/1/2017
Loyola University Medical Center
mi
from
Chicago, IL
DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
DECAAF: DE-MRI Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
Status: Enrolling
Updated: 6/1/2017
Loyola University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials